Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3528869A in Chronic Hepatitis B
NCT03866187Phase 2Terminated
- Sponsor
- GSK
- Start
- Mar 2019
- Primary completion
- Oct 2024
- Countries
- 9
01
Overview
Phase 2, randomised, single-blind trial of GSK3528869A in Chronic Hepatitis B (CHB), sponsored by GSK. Primary endpoints: Number of Participants Reporting Any Solicited Administration Site Events, Number of Participants Reporting Any Solicited Systemic Events and 1 more. Started Mar 2019; status: terminated.
02
Drugs
GSK3528869A
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03866187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03866187.